Does IL-31 level have more significance in chronic urticaria, when compared with IL-33 level? [PDF]
Postepy Dermatol AlergolÖzden G +5 more
europepmc +1 more source
Anti-IgE Antibody Therapy for Japanese Cedar Pollinosis: Omalizumab Update
, 2008 Kimihiro Okubo, Toshikazu Nagakura
openalex +1 more source
Systematic review and meta-analysis of omalizumab for IgE-mediated food allergy in children and young adults. [PDF]
Front ImmunolZhang Y, Liang B, Tian L, Chen B, Wu S.
europepmc +1 more source
Efficacy and Safety of Omalizumab Combined with Allergen-Specific Immunotherapy in the Treatment of Moderate-to-Severe Allergic Asthma: A Prospective Cohort Study in a Chinese Population. [PDF]
J Asthma AllergyLiu N +9 more
europepmc +1 more source
Predictors of Early Response and Relapse in Chronic Spontaneous Urticaria Treated with Omalizumab: The Role of Age, Sex, Disease Duration, and UAS7. [PDF]
Dermatol Pract ConceptGüner ME +4 more
europepmc +1 more source
Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: A comparison of 3-year follow-up results from two prospective multicentre studies [PDF]
, 2017 Bansal, Sandeep +10 more
core +2 more sources
Which Is the Best Biologic for Nasal Polyps: An Updated Network Meta-Analysis. [PDF]
Clin Transl AllergyXu X, Lin J, Luo M, Wu Q.
europepmc +1 more source
Predicting relapse in chronic spontaneous urticaria: A retrospective cohort study evaluating omalizumab withdrawal regimens [PDF]
Aleksandra Kucharczyk +6 more
openalex +1 more source
Machine learning-derived genetic risk scores identify IL21 as a predictor of response to omalizumab and dupilumab in asthma. [PDF]
Front AllergyAkenroye A +5 more
europepmc +1 more source
A case of joint and Achilles tendon injuries in an Adult T2 asthma treated with omalizumab
Yujin Zhu, Haiyang Ma, Guojing Han
openalex +1 more source